MARATTO

article · Frontiers in Pharmacology

Development and pharmacokinetic evaluation of granisetron hydrochloride buccal tablets for optimized chemotherapy-induced nausea and vomiting (CINV) relief

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The optimized buccal system provides controlled release and enhanced pharmacokinetic performance, suggesting a promising alternative approach for effective CINV management.

Research topics

  • Nausea and vomiting management
  • Chemotherapy-induced organ toxicity mitigation
  • Complementary and Alternative Medicine Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3389/fphar.2026.1731072

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.